Biotechnology
The Biotechnology industry has a total of 677 stocks, with a combined market cap of $896.43 billion and total revenue of $94.5 billion.
Market Cap
896.43B
Revenue
94.5B
Profits
-49.8B
PE Ratio
n/a
Profit Margin
-52.69%
Dividend Yield
0.19%
663 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.35B | 0.81% | 1,315,240 | 11.02B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.95B | 0.62% | 727,315 | 14.20B |
| 3 | ARGX | argenx SE | 39.32B | -0.46% | 208,646 | 1.91B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.44B | -0.16% | 542,016 | 2.25B |
| 5 | BNTX | BioNTech SE | 28.77B | 1.81% | 1,360,614 | 3.39B |
| 6 | ONC | BeiGene, Ltd. | 27.25B | 4.57% | 811,098 | 3.35B |
| 7 | RPRX | Royalty Pharma plc | 19.27B | 0.94% | 4,303,768 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 16.31B | -4.08% | 3,318,553 | - |
| 9 | UTHR | United Therapeutics Corporation | 16.12B | -1.70% | 376,340 | 2.76B |
| 10 | INSM | Insmed Incorporated | 14.67B | -3.05% | 2,594,096 | 363.71M |
| 11 | GMAB | Genmab A/S | 14.09B | -0.45% | 1,047,034 | 2.99B |
| 12 | INCY | Incyte Corporation | 13.96B | 1.02% | 1,287,509 | 4.24B |
| 13 | MRNA | Moderna, Inc. | 13.71B | 5.34% | 21,034,952 | 3.24B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 13.02B | -0.70% | 2,230,599 | 2.85B |
| 15 | EXEL | Exelixis, Inc. | 10.31B | 5.02% | 3,409,359 | 2.17B |
| 16 | TECH | Bio-Techne Corporation | 10.26B | -0.87% | 1,853,694 | 1.20B |
| 17 | SRPT | Sarepta Therapeutics, Inc. | 10.15B | -1.96% | 635,914 | 1.64B |
| 18 | PCVX | Vaxcyte, Inc. | 9.94B | -3.31% | 1,217,192 | - |
| 19 | ASND | Ascendis Pharma A/S | 9.12B | -1.39% | 310,323 | 376.48M |
| 20 | JAZZ | Jazz Pharmaceuticals plc | 8.22B | -0.47% | 539,185 | 3.99B |
| 21 | RVMD | Revolution Medicines, Inc. | 7.64B | -2.18% | 1,030,991 | 742.00K |
| 22 | ROIV | Roivant Sciences Ltd. | 7.62B | -0.37% | 3,954,358 | 122.59M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 7.33B | -4.22% | 247,945 | 76.81M |
| 24 | LEGN | Legend Biotech Corporation | 7.28B | 2.00% | 970,848 | 520.18M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 7.11B | 0.54% | 1,193,622 | 1.02B |
| 26 | BBIO | BridgeBio Pharma, Inc. | 6.96B | 0.12% | 2,429,345 | 221.90M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 6.72B | 6.70% | 1,470,789 | 385.69M |
| 28 | CORT | Corcept Therapeutics Incorporated | 6.66B | -2.38% | 1,150,818 | 628.56M |
| 29 | TLX | Telix Pharmaceuticals Limited | 6.37B | 12.00% | 39,652 | 484.69M |
| 30 | CYTK | Cytokinetics, Incorporated | 5.93B | -1.68% | 2,097,872 | 3.22M |
| 31 | BPMC | Blueprint Medicines Corporation | 5.90B | -2.23% | 777,180 | 508.82M |
| 32 | NUVL | Nuvalent, Inc. | 5.65B | -3.52% | 319,582 | - |
| 33 | VRNA | Verona Pharma plc | 5.56B | 5.87% | 2,072,643 | 5.62M |
| 34 | KRYS | Krystal Biotech, Inc. | 5.41B | 2.87% | 288,471 | 290.52M |
| 35 | IONS | Ionis Pharmaceuticals, Inc. | 5.14B | -1.13% | 1,529,680 | 705.14M |
| 36 | TGTX | TG Therapeutics, Inc. | 4.43B | -0.19% | 1,599,808 | 264.79M |
| 37 | SWTX | SpringWorks Therapeutics, Inc. | 4.36B | -2.80% | 3,332,728 | 191.59M |
| 38 | CRSP | CRISPR Therapeutics AG | 4.11B | -5.00% | 2,667,701 | 37.31M |
| 39 | AKRO | Akero Therapeutics, Inc. | 3.95B | 2.49% | 816,644 | - |
| 40 | RARE | Ultragenyx Pharmaceutical Inc. | 3.94B | -4.25% | 616,022 | 560.23M |
| 41 | PTCT | PTC Therapeutics, Inc. | 3.91B | 0.62% | 386,032 | 900.66M |
| 42 | VKTX | Viking Therapeutics, Inc. | 3.80B | 7.71% | 15,664,429 | - |
| 43 | ADMA | ADMA Biologics, Inc. | 3.74B | -1.49% | 2,016,465 | 382.81M |
| 44 | BHVN | Biohaven Ltd. | 3.73B | -7.19% | 835,605 | - |
| 45 | RNA | Avidity Biosciences, Inc. | 3.71B | -4.33% | 1,425,587 | 10.12M |
| 46 | ZLAB | Zai Lab Limited | 3.68B | 9.00% | 2,034,311 | 355.75M |
| 47 | RXRX | Recursion Pharmaceuticals, Inc. | 3.66B | -10.34% | 31,119,550 | 65.18M |
| 48 | IMVT | Immunovant, Inc. | 3.61B | 4.01% | 926,054 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 3.53B | -3.70% | 696,902 | - |
| 50 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.47B | 1.63% | 909,666 | 1.04M |
| 51 | ACLX | Arcellx, Inc. | 3.45B | -2.83% | 589,874 | 155.82M |
| 52 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.45B | -2.89% | 406,232 | 112.53M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 3.42B | -2.93% | 1,121,765 | 715.22M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 3.32B | -1.68% | 1,906,825 | 929.24M |
| 55 | MTSR | Metsera, Inc. | 3.26B | 0.03% | 151,400 | - |
| 56 | MRUS | Merus N.V. | 3.24B | -0.55% | 613,449 | 35.93M |
| 57 | XENE | Xenon Pharmaceuticals Inc. | 3.03B | 0.89% | 229,703 | - |
| 58 | DNLI | Denali Therapeutics Inc. | 2.98B | -3.98% | 802,383 | - |
| 59 | FOLD | Amicus Therapeutics, Inc. | 2.76B | 1.32% | 2,534,263 | 528.30M |
| 60 | MLTX | MoonLake Immunotherapeutics | 2.67B | 0.55% | 207,304 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.58B | -1.95% | 917,498 | 460.48M |
| 62 | VCEL | Vericel Corporation | 2.57B | -4.25% | 407,609 | 226.84M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 2.56B | -0.11% | 1,026,704 | - |
| 64 | MIRM | Mirum Pharmaceuticals, Inc. | 2.52B | -1.34% | 905,215 | 307.03M |
| 65 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.51B | -5.06% | 1,176,617 | 2.50M |
| 66 | IBRX | ImmunityBio, Inc. | 2.50B | -6.04% | 5,154,509 | 7.33M |
| 67 | BEAM | Beam Therapeutics Inc. | 2.42B | -8.18% | 1,883,556 | 349.64M |
| 68 | KYMR | Kymera Therapeutics, Inc. | 2.38B | -1.63% | 383,210 | 87.56M |
| 69 | PTGX | Protagonist Therapeutics, Inc. | 2.31B | 0.68% | 583,973 | 434.43M |
| 70 | LGND | Ligand Pharmaceuticals Incorporated | 2.28B | -1.10% | 132,003 | 152.42M |
| 71 | CNTA | Centessa Pharmaceuticals plc | 2.19B | -0.72% | 566,064 | 6.85M |
| 72 | MESO | Mesoblast Limited | 2.14B | -4.99% | 185,062 | 5.90M |
| 73 | CGON | CG Oncology, Inc. | 2.12B | -1.31% | 354,778 | 684.00K |
| 74 | JANX | Janux Therapeutics, Inc. | 2.08B | -3.12% | 619,140 | 13.05M |
| 75 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 4.36% | 958,897 | 36.50M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 1.99B | -2.72% | 311,290 | - |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 1.99B | -2.26% | 558,451 | 33.59M |
| 78 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -0.95% | 599,896 | 681.88M |
| 79 | APGE | Apogee Therapeutics, Inc. | 1.97B | 1.77% | 643,219 | - |
| 80 | TVTX | Travere Therapeutics, Inc. | 1.95B | -6.79% | 2,983,276 | 233.18M |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 1.91B | 0.55% | 871,390 | 7.00M |
| 82 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.91B | -1.92% | 5,467,726 | 412.58M |
| 83 | IRON | Disc Medicine, Inc. | 1.84B | 0.33% | 424,748 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 1.83B | -1.81% | 465,340 | 129.62M |
| 85 | VERA | Vera Therapeutics, Inc. | 1.81B | -3.48% | 1,180,025 | - |
| 86 | GLPG | Galapagos NV | 1.77B | 0.04% | 285,264 | 285.38M |
| 87 | IOVA | Iovance Biotherapeutics, Inc. | 1.76B | 3.03% | 10,818,757 | 90.86M |
| 88 | BLTE | Belite Bio, Inc | 1.76B | -0.44% | 8,406 | - |
| 89 | AAPG | Ascentage Pharma Group International | 1.75B | 7.63% | 166,219 | 124.27M |
| 90 | WVE | Wave Life Sciences Ltd. | 1.70B | -1.77% | 775,342 | 53.61M |
| 91 | BTX | BlackRock Innovation and Growth Term Trust | 1.68B | -2.54% | 757,664 | - |
| 92 | MNKD | MannKind Corporation | 1.59B | 1.77% | 1,881,750 | 267.20M |
| 93 | GERN | Geron Corporation | 1.55B | -2.28% | 8,792,988 | 29.48M |
| 94 | ETNB | 89bio, Inc. | 1.54B | 0.91% | 849,835 | - |
| 95 | ARQT | Arcutis Biotherapeutics, Inc. | 1.52B | -2.98% | 1,778,439 | 138.71M |
| 96 | IMCR | Immunocore Holdings plc | 1.50B | 0.17% | 58,151 | 296.31M |
| 97 | CLDX | Celldex Therapeutics, Inc. | 1.49B | -0.58% | 465,659 | 9.98M |
| 98 | PRAX | Praxis Precision Medicines, Inc. | 1.43B | -6.35% | 484,706 | 1.61M |
| 99 | DYN | Dyne Therapeutics, Inc. | 1.43B | 0.14% | 1,166,163 | - |
| 100 | SNDX | Syndax Pharmaceuticals, Inc. | 1.40B | 2.44% | 4,008,379 | 16.00M |
| 101 | LQDA | Liquidia Corporation | 1.36B | -2.33% | 558,360 | 15.61M |
| 102 | GPCR | Structure Therapeutics Inc. | 1.36B | 1.60% | 724,701 | - |
| 103 | FTRE | Fortrea Holdings Inc. | 1.33B | -4.68% | 766,992 | 2.98B |
| 104 | VIR | Vir Biotechnology, Inc. | 1.32B | -2.35% | 711,189 | 78.62M |
| 105 | VRDN | Viridian Therapeutics, Inc. | 1.29B | -2.11% | 819,245 | 302.00K |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.28B | -1.00% | 507,878 | 54.55M |
| 107 | NVAX | Novavax, Inc. | 1.28B | 0.88% | 10,033,793 | 885.19M |
| 108 | DAWN | Day One Biopharmaceuticals, Inc. | 1.25B | 1.64% | 758,249 | 101.95M |
| 109 | SYRE | Spyre Therapeutics, Inc. | 1.25B | -5.00% | 790,123 | - |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.24B | -0.65% | 4,441,777 | 43.09M |
| 111 | ADPT | Adaptive Biotechnologies Corporation | 1.22B | -0.72% | 1,394,652 | 178.96M |
| 112 | ARVN | Arvinas, Inc. | 1.22B | -3.27% | 1,871,318 | 263.40M |
| 113 | ARDX | Ardelyx, Inc. | 1.21B | -11.54% | 6,741,113 | 333.62M |
| 114 | MDXG | MiMedx Group, Inc. | 1.17B | 1.66% | 583,559 | 342.80M |
| 115 | AUPH | Aurinia Pharmaceuticals Inc. | 1.14B | 1.28% | 982,252 | 220.36M |
| 116 | INVA | Innoviva, Inc. | 1.13B | 0.06% | 302,235 | 352.75M |
| 117 | XNCR | Xencor, Inc. | 1.10B | -0.32% | 424,388 | 85.16M |
| 118 | OCUL | Ocular Therapeutix, Inc. | 1.10B | -3.45% | 638,578 | 61.44M |
| 119 | RCKT | Rocket Pharmaceuticals, Inc. | 1.09B | -3.68% | 1,031,647 | - |
| 120 | SPRY | ARS Pharmaceuticals, Inc. | 1.09B | -4.58% | 1,340,229 | 2.57M |
| 121 | REPL | Replimune Group, Inc. | 1.08B | -2.31% | 674,830 | - |
| 122 | ELVN | Enliven Therapeutics, Inc. | 1.07B | 1.54% | 152,168 | - |
| 123 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.04B | 4.05% | 5,404,575 | 276.92M |
| 124 | RCUS | Arcus Biosciences, Inc. | 1.01B | 3.07% | 1,238,479 | 263.00M |
| 125 | ZYME | Zymeworks Inc. | 991.15M | 2.64% | 342,619 | 62.20M |
| 126 | GYRE | Gyre Therapeutics, Inc. | 990.39M | -8.12% | 59,520 | 105.03M |
| 127 | AVBP | ArriVent BioPharma, Inc. | 912.18M | -1.17% | 116,783 | - |
| 128 | OCS | Oculis Holding AG | 898.04M | 0.47% | 20,908 | 1.03M |
| 129 | ABCL | AbCellera Biologics Inc. | 894.96M | -3.50% | 2,327,202 | 32.96M |
| 130 | PHVS | Pharvaris N.V. | 894.30M | -0.06% | 59,038 | - |
| 131 | COGT | Cogent Biosciences, Inc. | 883.69M | -1.11% | 920,838 | - |
| 132 | SION | Sionna Therapeutics, Inc. | 871.59M | -1.72% | 185,432 | - |
| 133 | PRTA | Prothena Corporation plc | 837.26M | 2.03% | 732,645 | 135.16M |
| 134 | BCYC | Bicycle Therapeutics plc | 805.08M | -2.83% | 488,864 | 36.90M |
| 135 | IMNM | Immunome, Inc. | 778.47M | -5.84% | 674,064 | 10.13M |
| 136 | GHRS | GH Research PLC | 775.97M | -10.64% | 371,508 | - |
| 137 | OPT | Opthea Limited | 761.46M | 0.60% | 11,286 | 261.86K |
| 138 | NUVB | Nuvation Bio Inc. | 743.81M | -2.64% | 1,743,866 | 2.16M |
| 139 | CVAC | CureVac N.V. | 740.24M | 0.61% | 1,158,318 | 70.57M |
| 140 | AVXL | Anavex Life Sciences Corp. | 710.29M | -3.80% | 1,021,900 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 707.40M | -5.93% | 348,857 | - |
| 142 | DNTH | Dianthus Therapeutics, Inc. | 700.56M | -0.13% | 288,754 | 5.37M |
| 143 | TYRA | Tyra Biosciences, Inc. | 692.78M | 3.05% | 187,609 | - |
| 144 | QURE | uniQure N.V. | 686.14M | -0.93% | 733,162 | 28.59M |
| 145 | CAPR | Capricor Therapeutics, Inc. | 682.05M | -0.99% | 1,245,390 | 23.23M |
| 146 | SANA | Sana Biotechnology, Inc. | 672.04M | -1.63% | 2,227,500 | - |
| 147 | RLAY | Relay Therapeutics, Inc. | 656.14M | -4.16% | 1,402,827 | 10.01M |
| 148 | ABUS | Arbutus Biopharma Corporation | 648.06M | -0.58% | 950,364 | 6.74M |
| 149 | LENZ | LENZ Therapeutics, Inc. | 646.00M | -5.81% | 111,604 | - |
| 150 | KURA | Kura Oncology, Inc. | 641.55M | 1.23% | 946,572 | - |
| 151 | VALN | Valneva SE | 629.25M | -5.94% | 51,801 | 176.82M |
| 152 | PHAR | Pharming Group N.V. | 620.37M | -1.01% | 2,778 | 285.75M |
| 153 | VERV | Verve Therapeutics, Inc. | 616.35M | -7.02% | 1,176,339 | 24.40M |
| 154 | CRMD | CorMedix Inc. | 614.66M | -6.38% | 799,012 | 12.26M |
| 155 | DNA | Ginkgo Bioworks Holdings, Inc. | 574.35M | -5.34% | 2,023,205 | 217.95M |
| 156 | MGTX | MeiraGTx Holdings plc | 570.52M | 6.88% | 946,621 | 13.93M |
| 157 | ABSI | Absci Corporation | 569.68M | -4.43% | 4,937,209 | 4.21M |
| 158 | ANAB | AnaptysBio, Inc. | 565.67M | -1.48% | 596,020 | 57.17M |
| 159 | SVRA | Savara Inc. | 563.45M | - | 641,563 | - |
| 160 | MNMD | Mind Medicine (MindMed) Inc. | 559.52M | -6.72% | 2,119,198 | - |
| 161 | PGEN | Precigen, Inc. | 559.38M | -3.05% | 1,121,162 | 3.96M |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 559.06M | -5.54% | 2,293,477 | 187.36M |
| 163 | IMTX | Immatics N.V. | 549.04M | - | 1,709,882 | 128.82M |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 545.49M | 2.81% | 1,056,886 | - |
| 165 | OMER | Omeros Corporation | 531.98M | -4.47% | 567,029 | - |
| 166 | MAZE | Maze Therapeutics, Inc. | 529.26M | -0.66% | 226,529 | 167.50M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 525.80M | -1.31% | 308,297 | - |
| 168 | AUTL | Autolus Therapeutics plc | 518.94M | - | 1,046,313 | 10.09M |
| 169 | ABVX | ABIVAX Société Anonyme | 505.36M | 6.04% | 46,657 | 9.68M |
| 170 | KALV | KalVista Pharmaceuticals, Inc. | 495.66M | -5.73% | 439,601 | - |
| 171 | RNAC | Cartesian Therapeutics, Inc. | 494.95M | -1.89% | 54,854 | 47.94M |
| 172 | CADL | Candel Therapeutics, Inc. | 493.99M | -4.75% | 1,616,464 | - |
| 173 | CELC | Celcuity Inc. | 488.25M | 0.15% | 314,016 | - |
| 174 | ARCT | Arcturus Therapeutics Holdings Inc. | 481.34M | 5.02% | 428,429 | 160.40M |
| 175 | MLYS | Mineralys Therapeutics, Inc. | 476.43M | 0.31% | 333,943 | - |
| 176 | RAPP | Rapport Therapeutics, Inc. | 463.79M | -2.46% | 149,293 | - |
| 177 | CMRX | Chimerix, Inc. | 463.17M | -0.39% | 1,966,326 | 159.00K |
| 178 | TRDA | Entrada Therapeutics, Inc. | 461.69M | -0.23% | 92,021 | 215.23M |
| 179 | TBPH | Theravance Biopharma, Inc. | 458.06M | -3.57% | 246,098 | 63.19M |
| 180 | ALT | Altimmune, Inc. | 457.33M | -3.02% | 1,637,662 | 52.00K |
| 181 | HUMA | Humacyte, Inc. | 455.49M | -5.60% | 1,605,983 | - |
| 182 | ALLO | Allogene Therapeutics, Inc. | 454.99M | -3.77% | 4,831,212 | 43.00K |
| 183 | SAGE | Sage Therapeutics, Inc. | 449.43M | 2.24% | 1,926,954 | 41.24M |
| 184 | KROS | Keros Therapeutics, Inc. | 446.39M | -0.09% | 867,902 | 651.00K |
| 185 | OABI | OmniAb, Inc. | 441.70M | -5.93% | 635,557 | 20.41M |
| 186 | MREO | Mereo BioPharma Group plc | 441.46M | -0.70% | 815,758 | 1.00M |
| 187 | STOK | Stoke Therapeutics, Inc. | 441.21M | -4.69% | 1,043,838 | 16.74M |
| 188 | PROK | ProKidney Corp. | 437.49M | -1.32% | 309,811 | - |
| 189 | TECX | Tectonic Therapeutic, Inc. | 435.79M | -4.20% | 316,779 | - |
| 190 | EYPT | EyePoint Pharmaceuticals, Inc. | 431.48M | -3.15% | 603,657 | 45.71M |
| 191 | PRTC | PureTech Health plc | 429.78M | 0.65% | 159 | 468.00K |
| 192 | URGN | UroGen Pharma Ltd. | 429.15M | -5.88% | 785,534 | 89.36M |
| 193 | UPB | Upstream Bio, Inc. | 427.70M | -3.04% | 135,535 | 2.21M |
| 194 | TRVI | Trevi Therapeutics, Inc. | 411.08M | -4.17% | 1,847,330 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 409.93M | -1.92% | 323,342 | 24.49M |
| 196 | CMPX | Compass Therapeutics, Inc. | 401.76M | -5.19% | 1,118,530 | 850.00K |
| 197 | ERAS | Erasca, Inc. | 398.65M | -3.42% | 842,548 | - |
| 198 | ALDX | Aldeyra Therapeutics, Inc. | 398.39M | -0.45% | 342,332 | - |
| 199 | PHAT | Phathom Pharmaceuticals, Inc. | 387.70M | 2.35% | 708,334 | 26.27M |
| 200 | ATXS | Astria Therapeutics, Inc. | 384.32M | -0.15% | 201,687 | - |
| 201 | GLUE | Monte Rosa Therapeutics, Inc. | 382.13M | -6.18% | 531,053 | 14.98M |
| 202 | PRME | Prime Medicine, Inc. | 378.32M | -5.27% | 797,728 | 800.00K |
| 203 | AURA | Aura Biosciences, Inc. | 375.14M | -1.57% | 146,728 | - |
| 204 | OLMA | Olema Pharmaceuticals, Inc. | 370.27M | -1.77% | 490,686 | - |
| 205 | MBX | MBX Biosciences, Inc. | 363.58M | -8.03% | 136,615 | - |
| 206 | ATYR | aTyr Pharma, Inc. | 362.63M | -2.48% | 1,752,230 | 235.00K |
| 207 | RGNX | REGENXBIO Inc. | 360.19M | -1.22% | 586,250 | 84.33M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 353.89M | -3.55% | 124,444 | 157.37M |
| 209 | TERN | Terns Pharmaceuticals, Inc. | 340.18M | -3.03% | 1,034,882 | - |
| 210 | CDXS | Codexis, Inc. | 340.16M | -1.88% | 649,048 | 64.45M |
| 211 | ATAI | Atai Life Sciences N.V. | 333.93M | -2.45% | 3,682,241 | 331.00K |
| 212 | TSHA | Taysha Gene Therapies, Inc. | 329.96M | -1.83% | 1,637,693 | 9.92M |
| 213 | ZBIO | Zenas BioPharma, Inc. | 327.22M | 0.26% | 171,218 | - |
| 214 | ENGN | enGene Holdings Inc. | 320.64M | 2.78% | 81,624 | - |
| 215 | ENGNW | enGene Holdings Inc. | 320.64M | -10.79% | 48,530 | - |
| 216 | GOSS | Gossamer Bio, Inc. | 317.25M | -8.50% | 1,580,146 | 105.32M |
| 217 | CRDF | Cardiff Oncology, Inc. | 315.99M | 1.06% | 1,046,493 | 688.00K |
| 218 | TRML | Tourmaline Bio, Inc. | 313.10M | -1.29% | 214,054 | - |
| 219 | ANNX | Annexon, Inc. | 299.53M | -0.71% | 558,349 | - |
| 220 | AARD | Aardvark Therapeutics, Inc. | 293.82M | -20.35% | 236,643 | - |
| 221 | NMRA | Neumora Therapeutics, Inc. | 290.81M | 5.26% | 2,116,350 | - |
| 222 | FHTX | Foghorn Therapeutics Inc. | 290.75M | -2.79% | 183,495 | 25.52M |
| 223 | IMMP | Immutep Limited | 283.04M | -2.54% | 77,665 | 2.56M |
| 224 | ALMS | Alumis Inc. | 281.29M | 0.78% | 453,320 | - |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 278.37M | -1.51% | 74,605 | - |
| 226 | DSGN | Design Therapeutics, Inc. | 278.01M | -2.00% | 298,187 | - |
| 227 | XOMA | XOMA Royalty Corporation | 277.13M | -4.16% | 46,945 | 21.61M |
| 228 | RZLT | Rezolute, Inc. | 274.23M | -2.16% | 354,648 | - |
| 229 | ITOS | iTeos Therapeutics, Inc. | 270.72M | -0.94% | 261,934 | 35.00M |
| 230 | CRVS | Corvus Pharmaceuticals, Inc. | 269.24M | -4.99% | 1,010,238 | - |
| 231 | BNTC | Benitec Biopharma Inc. | 265.00M | -2.33% | 16,101 | - |
| 232 | PRQR | ProQR Therapeutics N.V. | 264.20M | -0.78% | 163,594 | 20.51M |
| 233 | HRTX | Heron Therapeutics, Inc. | 263.12M | 0.58% | 1,144,725 | 137.74M |
| 234 | ACIU | AC Immune SA | 262.19M | -0.38% | 161,166 | 48.51M |
| 235 | AVIR | Atea Pharmaceuticals, Inc. | 260.99M | -1.59% | 297,790 | - |
| 236 | SLRN | Acelyrin, Inc. | 260.85M | 19.82% | 12,538,501 | - |
| 237 | VSTM | Verastem, Inc. | 260.85M | 1.97% | 502,457 | 10.00M |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 258.34M | -1.34% | 562,698 | 198.77M |
| 239 | IVA | Inventiva S.A. | 257.95M | 0.35% | 35,353 | 20.65M |
| 240 | NGNE | Neurogene Inc. | 257.88M | 0.29% | 134,739 | 925.00K |
| 241 | SEPN | Septerna, Inc. | 257.54M | -1.53% | 1,093,779 | 981.00K |
| 242 | LXRX | Lexicon Pharmaceuticals, Inc. | 256.66M | -2.20% | 3,148,968 | 5.23M |
| 243 | ELDN | Eledon Pharmaceuticals, Inc. | 256.28M | -1.15% | 146,534 | - |
| 244 | YMAB | Y-mAbs Therapeutics, Inc. | 256.19M | -5.30% | 288,638 | 84.55M |
| 245 | DRUG | Bright Minds Biosciences Inc. | 253.68M | -0.44% | 62,451 | - |
| 246 | TNGX | Tango Therapeutics, Inc. | 253.51M | -2.88% | 530,989 | 43.38M |
| 247 | NNNN | Anbio Biotechnology | 253.25M | 1.76% | 140,112 | 9.50M |
| 248 | ABEO | Abeona Therapeutics Inc. | 251.26M | -0.69% | 166,378 | - |
| 249 | TVGN | Tevogen Bio Holdings Inc. | 247.70M | -8.71% | 805,466 | - |
| 250 | KRRO | Korro Bio, Inc. | 246.29M | -8.24% | 82,519 | - |
| 251 | MNPR | Monopar Therapeutics Inc. | 245.46M | -1.76% | 45,454 | - |
| 252 | CDTX | Cidara Therapeutics, Inc. | 235.62M | -3.75% | 51,750 | 44.65M |
| 253 | KOD | Kodiak Sciences Inc. | 233.63M | -6.12% | 216,675 | - |
| 254 | SLDB | Solid Biosciences Inc. | 230.94M | -3.67% | 2,141,295 | - |
| 255 | VYGR | Voyager Therapeutics, Inc. | 230.52M | -0.94% | 260,687 | 163.78M |
| 256 | SLN | Silence Therapeutics plc | 226.16M | -4.20% | 134,928 | 21.77M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 224.67M | -6.25% | 478,542 | 196.49M |
| 258 | SGMO | Sangamo Therapeutics, Inc. | 223.25M | -4.46% | 4,258,798 | 52.29M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 215.67M | 1.16% | 32,149 | - |
| 260 | FDMT | 4D Molecular Therapeutics, Inc. | 214.50M | -0.64% | 551,750 | 17.00K |
| 261 | CCCC | C4 Therapeutics, Inc. | 212.47M | 0.67% | 851,729 | 33.67M |
| 262 | IVVD | Invivyd, Inc. | 211.72M | 46.28% | 37,505,402 | 11.56M |
| 263 | FULC | Fulcrum Therapeutics, Inc. | 207.66M | - | 279,988 | 80.87M |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 206.01M | -8.90% | 266,057 | 1.00 |
| 265 | LYEL | Lyell Immunopharma, Inc. | 204.72M | 6.17% | 1,094,328 | 63.00K |
| 266 | LRMR | Larimar Therapeutics, Inc. | 203.54M | -2.45% | 511,336 | - |
| 267 | OCGN | Ocugen, Inc. | 198.48M | -2.88% | 2,505,876 | 4.70M |
| 268 | CTNM | Contineum Therapeutics, Inc. | 195.65M | -3.92% | 61,602 | - |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 193.37M | -3.75% | 68,912 | - |
| 270 | GNFT | Genfit S.A. | 192.83M | -2.30% | 9,870 | 86.23M |
| 271 | IPHA | Innate Pharma S.A. | 192.71M | 1.36% | 116,557 | 36.20M |
| 272 | CYBN | Cybin Inc. | 191.22M | -2.57% | 282,467 | - |
| 273 | MDWD | MediWound Ltd. | 190.77M | -5.00% | 22,589 | 19.72M |
| 274 | INMB | INmune Bio, Inc. | 190.46M | -5.50% | 270,475 | 42.00K |
| 275 | CGEN | Compugen Ltd. | 188.03M | -3.67% | 300,928 | 59.85M |
| 276 | DRTS | Alpha Tau Medical Ltd. | 187.88M | -6.62% | 50,604 | - |
| 277 | PLRX | Pliant Therapeutics, Inc. | 187.43M | 2.33% | 1,996,344 | - |
| 278 | ALEC | Alector, Inc. | 183.13M | 0.54% | 454,052 | 61.51M |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 182.68M | 0.76% | 55,704 | 49.35M |
| 280 | INBX | Inhibrx Biosciences, Inc. | 181.82M | -1.88% | 58,064 | 1.57M |
| 281 | NVCT | Nuvectis Pharma, Inc. | 181.43M | 0.93% | 91,419 | - |
| 282 | OBIO | Orchestra BioMed Holdings, Inc. | 179.42M | -9.23% | 70,513 | 2.65M |
| 283 | NBTX | Nanobiotix S.A. | 178.46M | -1.57% | 6,167 | 45.22M |
| 284 | PLX | Protalix BioTherapeutics, Inc. | 175.98M | -1.65% | 536,863 | 45.67M |
| 285 | MOLN | Molecular Partners AG | 175.89M | -9.98% | 2,707 | 7.11M |
| 286 | CRGX | CARGO Therapeutics, Inc. | 173.52M | 2.17% | 581,071 | - |
| 287 | MGNX | MacroGenics, Inc. | 173.23M | -4.17% | 597,260 | 141.33M |
| 288 | ACRV | Acrivon Therapeutics, Inc. | 172.50M | -5.30% | 40,053 | - |
| 289 | NKTR | Nektar Therapeutics | 171.95M | -2.58% | 1,180,387 | 93.14M |
| 290 | ENTA | Enanta Pharmaceuticals, Inc. | 171.30M | -4.18% | 611,085 | 66.59M |
| 291 | VOR | Vor Biopharma Inc. | 170.63M | -2.14% | 170,230 | - |
| 292 | EXOZ | eXoZymes, Inc. | 168.75M | 1.84% | 14,427 | -700.00 |
| 293 | ZNTL | Zentalis Pharmaceuticals, Inc. | 165.34M | -6.07% | 1,008,760 | 40.56M |
| 294 | RAPT | RAPT Therapeutics, Inc. | 165.01M | -0.79% | 293,813 | - |
| 295 | GNLX | Genelux Corporation | 164.04M | -0.21% | 141,448 | 8.00K |
| 296 | SCPH | scPharmaceuticals Inc. | 162.63M | -3.27% | 392,538 | 30.28M |
| 297 | VXRT | Vaxart, Inc. | 162.31M | 1.21% | 2,670,228 | 16.76M |
| 298 | FATE | Fate Therapeutics, Inc. | 161.73M | -8.09% | 2,165,132 | 13.45M |
| 299 | EDIT | Editas Medicine, Inc. | 158.49M | -6.80% | 9,389,990 | 61.76M |
| 300 | ADCT | ADC Therapeutics SA | 157.60M | -2.40% | 278,219 | 70.72M |
| 301 | CLLS | Cellectis S.A. | 157.13M | -0.65% | 76,635 | 36.04M |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 157.08M | -0.75% | 21,061 | - |
| 303 | THRD | Third Harmonic Bio, Inc. | 156.35M | -3.07% | 509,780 | - |
| 304 | LCTX | Lineage Cell Therapeutics, Inc. | 155.25M | -1.95% | 755,775 | 8.72M |
| 305 | CKPT | Checkpoint Therapeutics, Inc. | 152.85M | -1.57% | 611,831 | 47.00K |
| 306 | ACTU | Actuate Therapeutics, Inc. | 150.20M | -1.79% | 20,351 | - |
| 307 | STRO | Sutro Biopharma, Inc. | 145.95M | -3.28% | 453,849 | 160.96M |
| 308 | NKTX | Nkarta, Inc. | 144.67M | -4.65% | 1,967,877 | - |
| 309 | TIL | Instil Bio, Inc. | 144.35M | -7.87% | 117,996 | - |
| 310 | ADAP | Adaptimmune Therapeutics plc | 143.17M | -3.45% | 483,242 | 175.04M |
| 311 | PBYI | Puma Biotechnology, Inc. | 142.60M | -0.51% | 480,171 | 243.57M |
| 312 | HURA | TuHURA Biosciences, Inc. | 140.93M | 0.91% | 123,175 | - |
| 313 | CSBR | Champions Oncology, Inc. | 139.32M | -3.05% | 34,822 | 53.57M |
| 314 | MCRB | Seres Therapeutics, Inc. | 137.19M | -1.00% | 906,987 | 126.33M |
| 315 | MIST | Milestone Pharmaceuticals Inc. | 135.13M | -0.97% | 552,061 | - |
| 316 | TSVT | 2seventy bio, Inc. | 134.65M | -2.61% | 308,568 | 45.62M |
| 317 | SEER | Seer, Inc. | 133.26M | -1.31% | 310,516 | 14.61M |
| 318 | SGMT | Sagimet Biosciences Inc. | 132.64M | 2.36% | 661,420 | - |
| 319 | EPRX | Eupraxia Pharmaceuticals Inc. | 132.40M | 1.67% | 56,842 | - |
| 320 | RENB | Renovaro Inc. | 130.93M | -2.59% | 586,269 | - |
| 321 | LXEO | Lexeo Therapeutics, Inc. | 128.67M | -3.47% | 176,621 | - |
| 322 | TARA | Protara Therapeutics, Inc. | 127.67M | -5.82% | 270,327 | - |
| 323 | BMEA | Biomea Fusion, Inc. | 125.39M | -5.21% | 276,260 | - |
| 324 | VIGL | Vigil Neuroscience, Inc. | 123.73M | 4.84% | 759,290 | - |
| 325 | CHRS | Coherus BioSciences, Inc. | 123.28M | -2.73% | 1,536,688 | 304.34M |
| 326 | SAVA | Cassava Sciences, Inc. | 122.68M | -5.56% | 1,085,628 | - |
| 327 | TCRX | TScan Therapeutics, Inc. | 122.62M | -0.91% | 486,580 | 9.36M |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 122.22M | -5.26% | 384,176 | - |
| 329 | KYTX | Kyverna Therapeutics, Inc. | 120.02M | -2.11% | 342,429 | - |
| 330 | CRBU | Caribou Biosciences, Inc. | 118.62M | -7.09% | 777,165 | 11.48M |
| 331 | TELO | Telomir Pharmaceuticals, Inc. | 116.37M | -6.46% | 145,877 | - |
| 332 | IMUX | Immunic, Inc. | 114.40M | 7.63% | 2,123,176 | - |
| 333 | VTYX | Ventyx Biosciences, Inc. | 113.84M | -3.01% | 626,761 | - |
| 334 | ACHV | Achieve Life Sciences, Inc. | 109.02M | -1.55% | 148,982 | - |
| 335 | IFRX | InflaRx N.V. | 107.76M | -1.08% | 219,818 | 187.93K |
| 336 | COYA | Coya Therapeutics, Inc. | 107.09M | 3.89% | 265,857 | 9.55M |
| 337 | CABA | Cabaletta Bio, Inc. | 100.69M | -1.44% | 1,123,563 | - |
| 338 | ACOG | Alpha Cognition Inc. | 100.60M | -1.26% | 67,467 | - |
| 339 | ATOS | Atossa Therapeutics, Inc. | 100.04M | -5.32% | 563,886 | - |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 99.63M | -1.21% | 184,982 | - |
| 341 | ANIX | Anixa Biosciences, Inc. | 99.16M | -2.84% | 112,365 | - |
| 342 | CLYM | Climb Bio, Inc. | 98.82M | 2.08% | 459,862 | - |
| 343 | CAMP | Camp4 Therapeutics Corporation | 96.97M | -0.41% | 11,312 | - |
| 344 | RANI | Rani Therapeutics Holdings, Inc. | 95.33M | -4.05% | 225,809 | - |
| 345 | GALT | Galectin Therapeutics Inc. | 93.52M | 1.36% | 267,208 | - |
| 346 | ELTX | Elicio Therapeutics, Inc. | 92.03M | 5.43% | 43,081 | - |
| 347 | ARTV | Artiva Biotherapeutics, Inc. | 91.57M | -0.53% | 63,342 | 2.60M |
| 348 | ZURA | Zura Bio Limited | 91.41M | -2.78% | 175,037 | - |
| 349 | ADAG | Adagene Inc. | 91.20M | 0.98% | 13,933 | 815.75K |
| 350 | XBIT | XBiotech Inc. | 91.15M | -4.17% | 79,499 | - |
| 351 | SKYE | Skye Bioscience, Inc. | 90.41M | -4.79% | 122,576 | - |
| 352 | MNOV | MediciNova, Inc. | 89.75M | 3.10% | 24,282 | - |
| 353 | TLSA | Tiziana Life Sciences Ltd | 89.44M | -8.90% | 480,667 | - |
| 354 | JSPR | Jasper Therapeutics, Inc. | 89.41M | -3.25% | 495,258 | - |
| 355 | SLS | SELLAS Life Sciences Group, Inc. | 89.39M | -3.05% | 1,394,373 | - |
| 356 | MGX | Metagenomi, Inc. | 88.32M | -3.28% | 368,351 | 55.08M |
| 357 | AVTX | Avalo Therapeutics, Inc. | 88.31M | 17.88% | 47,861 | 820.00K |
| 358 | HLVX | HilleVax, Inc. | 88.27M | -2.14% | 79,616 | - |
| 359 | TNYA | Tenaya Therapeutics, Inc. | 87.93M | -1.77% | 981,442 | - |
| 360 | ORMP | Oramed Pharmaceuticals Inc. | 86.67M | -3.15% | 191,272 | - |
| 361 | ANRO | Alto Neuroscience, Inc. | 86.03M | 2.24% | 138,878 | - |
| 362 | RGLS | Regulus Therapeutics Inc. | 85.81M | 3.15% | 300,577 | - |
| 363 | THTX | Theratechnologies Inc. | 85.45M | -3.91% | 50,159 | 84.32M |
| 364 | DBVT | DBV Technologies S.A. | 85.42M | 3.41% | 8,122 | 12.52M |
| 365 | VTGN | Vistagen Therapeutics, Inc. | 84.57M | 2.09% | 279,307 | 698.00K |
| 366 | VERU | Veru Inc. | 83.83M | -2.88% | 1,964,246 | 16.89M |
| 367 | CUE | Cue Biopharma, Inc. | 83.62M | -3.65% | 108,707 | 9.53M |
| 368 | ABOS | Acumen Pharmaceuticals, Inc. | 83.51M | 0.72% | 397,611 | - |
| 369 | NTRB | Nutriband Inc. | 82.85M | 1.08% | 47,390 | 2.02M |
| 370 | ANL | Adlai Nortye Ltd. | 82.29M | -3.88% | 8,788 | 5.00M |
| 371 | IGMS | IGM Biosciences, Inc. | 82.06M | -0.72% | 160,612 | 2.92M |
| 372 | ADVM | Adverum Biotechnologies, Inc. | 81.96M | -1.01% | 163,430 | 1.00M |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 80.86M | 0.90% | 1,382,727 | 203.41K |
| 374 | INZY | Inozyme Pharma, Inc. | 80.30M | -1.57% | 705,196 | - |
| 375 | ACET | Adicet Bio, Inc. | 80.21M | -2.66% | 298,736 | - |
| 376 | XFOR | X4 Pharmaceuticals, Inc. | 79.66M | -1.33% | 955,790 | 1.12M |
| 377 | IMAB | I-Mab | 78.99M | 0.35% | 228,029 | 569.46K |
| 378 | ASMB | Assembly Biosciences, Inc. | 78.50M | -3.14% | 20,939 | 28.33M |
| 379 | AGEN | Agenus Inc. | 77.88M | -3.77% | 224,953 | 160.43M |
| 380 | ENTX | Entera Bio Ltd. | 77.35M | -4.11% | 29,978 | 99.00K |
| 381 | EPIX | ESSA Pharma Inc. | 76.35M | -1.71% | 59,748 | - |
| 382 | ARMP | Armata Pharmaceuticals, Inc. | 76.35M | 4.98% | 21,410 | 5.47M |
| 383 | PYXS | Pyxis Oncology, Inc. | 76.12M | -5.88% | 623,923 | 16.15M |
| 384 | KPTI | Karyopharm Therapeutics Inc. | 75.54M | -1.90% | 1,053,673 | 145.24M |
| 385 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 73.13M | -3.68% | 1,541,768 | - |
| 386 | CNTX | Context Therapeutics Inc. | 73.02M | 3.04% | 87,273 | - |
| 387 | PMVP | PMV Pharmaceuticals, Inc. | 72.96M | -0.70% | 128,631 | - |
| 388 | OKUR | OnKure Therapeutics, Inc. | 72.83M | - | 27,755 | - |
| 389 | IOBT | IO Biotech, Inc. | 72.47M | -0.90% | 82,976 | - |
| 390 | GNTA | Genenta Science S.p.A. | 72.43M | 0.76% | 2,428 | - |
| 391 | BYSI | BeyondSpring Inc. | 72.14M | 4.68% | 3,184 | 1.88M |
| 392 | CLSD | Clearside Biomedical, Inc. | 72.05M | -7.77% | 224,273 | 7.70M |
| 393 | FGEN | FibroGen, Inc. | 71.13M | -8.61% | 9,366,699 | 180.02M |
| 394 | CBUS | Cibus, Inc. | 70.53M | -3.70% | 185,024 | 4.15M |
| 395 | FBRX | Forte Biosciences, Inc. | 70.20M | 2.62% | 11,291 | - |
| 396 | MURA | Mural Oncology plc | 69.18M | -4.03% | 82,857 | - |
| 397 | ALGS | Aligos Therapeutics, Inc. | 69.15M | -10.65% | 337,448 | 6.00M |
| 398 | AADI | Aadi Bioscience, Inc. | 68.77M | -2.45% | 109,754 | 25.07M |
| 399 | AVTE | Aerovate Therapeutics, Inc. | 68.43M | -0.84% | 116,549 | - |
| 400 | GUTS | Fractyl Health, Inc. | 68.30M | -2.74% | 126,393 | 97.00K |
| 401 | VANI | Vivani Medical, Inc. | 68.12M | -2.54% | 47,942 | - |
| 402 | IKNA | Ikena Oncology, Inc. | 67.08M | -4.14% | 82,481 | 659.00K |
| 403 | VRCA | Verrica Pharmaceuticals Inc. | 66.66M | -0.78% | 252,387 | 9.21M |
| 404 | MRSN | Mersana Therapeutics, Inc. | 65.87M | 0.98% | 6,563,212 | 34.84M |
| 405 | STTK | Shattuck Labs, Inc. | 65.40M | 6.20% | 168,820 | 6.44M |
| 406 | VTVT | vTv Therapeutics Inc. | 64.43M | -4.94% | 6,768 | 1.00M |
| 407 | UNCY | Unicycive Therapeutics, Inc. | 64.03M | 1.15% | 1,380,317 | - |
| 408 | IPSC | Century Therapeutics, Inc. | 62.08M | -2.51% | 279,655 | 2.68M |
| 409 | APLT | Applied Therapeutics, Inc. | 61.67M | -6.23% | 3,288,230 | -212.00K |
| 410 | QNCX | Quince Therapeutics, Inc. | 61.60M | -3.45% | 44,278 | - |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 61.50M | - | 217,802 | 3.39M |
| 412 | CTMX | CytomX Therapeutics, Inc. | 61.04M | -4.42% | 458,883 | 126.62M |
| 413 | KRON | Kronos Bio, Inc. | 60.34M | -1.96% | 392,121 | 9.86M |
| 414 | GANX | Gain Therapeutics, Inc. | 60.21M | -2.99% | 142,653 | - |
| 415 | ALXO | ALX Oncology Holdings Inc. | 59.07M | - | 229,899 | - |
| 416 | RNTX | Rein Therapeutics Inc. | 58.50M | 0.75% | 118,601 | - |
| 417 | ACHL | Achilles Therapeutics plc | 56.72M | -0.72% | 943,672 | - |
| 418 | ONCY | Oncolytics Biotech Inc. | 55.88M | -1.79% | 230,947 | - |
| 419 | RPTX | Repare Therapeutics Inc. | 54.84M | -2.27% | 138,318 | 66.52M |
| 420 | IMRX | Immuneering Corporation | 54.65M | 2.92% | 452,435 | - |
| 421 | ESLA | Estrella Immunopharma, Inc. | 53.55M | -0.67% | 642,956 | - |
| 422 | DOMH | Dominari Holdings Inc. | 51.96M | -17.26% | 862,060 | 12.59M |
| 423 | ANEB | Anebulo Pharmaceuticals, Inc. | 51.77M | -10.00% | 12,534 | - |
| 424 | ITRM | Iterum Therapeutics plc | 51.53M | - | 313,614 | - |
| 425 | TNXP | Tonix Pharmaceuticals Holding Corp. | 51.26M | -5.17% | 599,422 | 11.29M |
| 426 | PDSB | PDS Biotechnology Corporation | 50.13M | -5.63% | 180,456 | - |
| 427 | OTLK | Outlook Therapeutics, Inc. | 49.95M | -4.88% | 752,964 | - |
| 428 | IMMX | Immix Biopharma, Inc. | 48.41M | -1.12% | 80,317 | - |
| 429 | MAIA | MAIA Biotechnology, Inc. | 48.39M | -2.63% | 66,862 | - |
| 430 | CNTB | Connect Biopharma Holdings Limited | 48.08M | 1.17% | 90,434 | 24.12M |
| 431 | PRLD | Prelude Therapeutics Incorporated | 47.93M | -3.50% | 161,053 | 3.00M |
| 432 | ALVR | AlloVir, Inc. | 47.92M | -0.41% | 5,065 | - |
| 433 | LTRN | Lantern Pharma Inc. | 46.70M | - | 69,455 | - |
| 434 | DTIL | Precision BioSciences, Inc. | 45.49M | 0.68% | 186,805 | 75.10M |
| 435 | SPRO | Spero Therapeutics, Inc. | 45.30M | -0.68% | 82,032 | 106.46M |
| 436 | ICCC | ImmuCell Corporation | 44.74M | 0.20% | 3,211 | 23.84M |
| 437 | FBIO | Fortress Biotech, Inc. | 44.72M | - | 320,968 | 81.50M |
| 438 | PEPG | PepGen Inc. | 44.66M | -4.86% | 209,460 | - |
| 439 | SER | Serina Therapeutics, Inc. | 44.42M | -3.27% | 6,511 | 3.16M |
| 440 | KZR | Kezar Life Sciences, Inc. | 44.14M | -5.47% | 7,621 | - |
| 441 | OVID | Ovid Therapeutics Inc. | 43.85M | 8.91% | 555,176 | 631.70K |
| 442 | BOLD | Boundless Bio, Inc. | 43.71M | -2.00% | 329,072 | - |
| 443 | DYAI | Dyadic International, Inc. | 43.50M | -2.00% | 22,365 | 3.36M |
| 444 | LSB | LakeShore Biopharma Co., Ltd | 42.55M | -3.46% | 12,355 | 79.42M |
| 445 | XLO | Xilio Therapeutics, Inc. | 42.52M | -12.26% | 3,245,150 | 4.62M |
| 446 | ABP | Abpro Holdings, Inc. | 42.29M | -11.95% | 101,672 | 230.00K |
| 447 | ATRA | Atara Biotherapeutics, Inc. | 40.95M | -5.45% | 101,397 | 100.44M |
| 448 | GBIO | Generation Bio Co. | 40.76M | -0.78% | 507,615 | 18.58M |
| 449 | ANVS | Annovis Bio, Inc. | 40.57M | -4.48% | 381,221 | - |
| 450 | KALA | KALA BIO, Inc. | 40.45M | -2.92% | 30,993 | - |
| 451 | VYNE | VYNE Therapeutics Inc. | 40.42M | 1.48% | 67,587 | 493.00K |
| 452 | BRNS | Barinthus Biotherapeutics plc | 40.23M | -6.54% | 5,610 | 14.97M |
| 453 | INKT | MiNK Therapeutics, Inc. | 40.03M | 1.10% | 6,245 | - |
| 454 | CLGN | CollPlant Biotechnologies Ltd. | 39.75M | 0.29% | 3,288 | 650.00K |
| 455 | BLUE | bluebird bio, Inc. | 39.67M | -42.05% | 5,413,116 | 53.12M |
| 456 | FBLG | FibroBiologics, Inc. | 39.47M | -9.27% | 284,518 | - |
| 457 | ATHE | Alterity Therapeutics Limited | 38.51M | -2.63% | 22,479 | 2.68M |
| 458 | CASI | CASI Pharmaceuticals, Inc. | 37.96M | -1.21% | 6,954 | 22.06M |
| 459 | OKYO | OKYO Pharma Limited | 37.84M | 1.36% | 109,146 | - |
| 460 | CELU | Celularity Inc. | 37.77M | -6.67% | 214,294 | 48.20M |
| 461 | TPST | Tempest Therapeutics, Inc. | 37.55M | -5.14% | 736,877 | - |
| 462 | ATNM | Actinium Pharmaceuticals, Inc. | 36.50M | -4.88% | 124,116 | 81.00K |
| 463 | SRZN | Surrozen, Inc. | 36.40M | -3.03% | 7,911 | 10.00M |
| 464 | OSTX | OS Therapies Incorporated | 36.11M | -10.05% | 372,203 | - |
| 465 | ELEV | Elevation Oncology, Inc. | 35.91M | -6.53% | 911,578 | - |
| 466 | RADX | Radiopharm Theranostics Limited | 35.71M | 0.41% | 3,900 | 1.31M |
| 467 | CVKD | Cadrenal Therapeutics, Inc. | 35.45M | 3.32% | 43,498 | - |
| 468 | IRD | Opus Genetics, Inc. | 34.73M | -0.90% | 120,435 | 8.38M |
| 469 | IBIO | iBio, Inc. | 34.36M | -4.13% | 249,991 | 375.00K |
| 470 | ANTX | AN2 Therapeutics, Inc. | 33.76M | - | 342,033 | - |
| 471 | INTS | Intensity Therapeutics, Inc. | 33.68M | 5.19% | 40,049 | - |
| 472 | GRCE | Grace Therapeutics, Inc. | 33.36M | -2.95% | 21,374 | - |
| 473 | UBX | Unity Biotechnology, Inc. | 32.69M | -5.37% | 98,758 | - |
| 474 | PULM | Pulmatrix, Inc. | 32.58M | -1.00% | 20,420 | 10.01M |
| 475 | PASG | Passage Bio, Inc. | 32.42M | -4.60% | 72,783 | - |
| 476 | GDTC | CytoMed Therapeutics Limited | 32.31M | 4.48% | 8,901 | 330.25K |
| 477 | CMMB | Chemomab Therapeutics Ltd. | 32.24M | -3.39% | 204,527 | - |
| 478 | CALC | CalciMedica, Inc. | 31.68M | -3.69% | 15,126 | - |
| 479 | QTTB | Q32 Bio Inc. | 31.30M | 5.76% | 379,015 | -14.66M |
| 480 | RLYB | Rallybio Corporation | 31.28M | -2.09% | 49,512 | 598.00K |
| 481 | EQ | Equillium, Inc. | 31.18M | -0.49% | 40,578 | 45.91M |
| 482 | CVM | CEL-SCI Corporation | 30.88M | -5.44% | 2,029,836 | - |
| 483 | PYPD | PolyPid Ltd. | 30.47M | -2.29% | 6,218 | - |
| 484 | PLUR | Pluri Inc. | 30.30M | -7.28% | 4,211 | 678.00K |
| 485 | MLEC | Moolec Science SA | 29.98M | 4.00% | 16,074 | 5.44M |
| 486 | DARE | Daré Bioscience, Inc. | 27.58M | 0.32% | 54,927 | 1.88M |
| 487 | NRXP | NRx Pharmaceuticals, Inc. | 27.50M | -6.94% | 322,643 | - |
| 488 | BIVI | BioVie Inc. | 27.31M | -9.20% | 595,136 | - |
| 489 | PMN | ProMIS Neurosciences, Inc. | 26.64M | -10.79% | 29,848 | - |
| 490 | CRIS | Curis, Inc. | 26.25M | - | 19,341 | 10.26M |
| 491 | PTN | Palatin Technologies, Inc. | 26.01M | -1.96% | 801,022 | 350.00K |
| 492 | XCUR | Exicure, Inc. | 25.98M | 1.54% | 9,402 | 500.00K |
| 493 | NKGN | NKGen Biotech, Inc. | 25.60M | 27.12% | 115,862,544 | - |
| 494 | ALLK | Allakos Inc. | 25.53M | -1.72% | 605,755 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 25.45M | 1.40% | 222,662 | 496.92K |
| 496 | NRSN | NeuroSense Therapeutics Ltd. | 25.21M | -0.91% | 102,012 | - |
| 497 | LVTX | LAVA Therapeutics N.V. | 25.18M | -0.26% | 5,580 | 7.35M |
| 498 | RNXT | RenovoRx, Inc. | 24.72M | - | 87,991 | - |
| 499 | IBO | Impact BioMedical Inc. | 24.39M | 6.00% | 13,035 | - |
| 500 | CGTX | Cognition Therapeutics, Inc. | 24.23M | -4.33% | 503,674 | - |
| 501 | AKTX | Akari Therapeutics, Plc | 24.02M | -7.62% | 29,865 | - |
| 502 | BCAB | BioAtla, Inc. | 23.68M | -9.03% | 887,494 | 11.00M |
| 503 | IGC | IGC Pharma, Inc. | 23.59M | -0.10% | 321,139 | 1.24M |
| 504 | NNVC | NanoViricides, Inc. | 23.46M | 3.45% | 416,281 | - |
| 505 | LGVN | Longeveron Inc. | 23.15M | -4.88% | 101,485 | 1.85M |
| 506 | TENX | Tenax Therapeutics, Inc. | 23.01M | 7.66% | 33,045 | - |
| 507 | CARA | Cara Therapeutics, Inc. | 22.72M | -2.93% | 21,156 | 8.69M |
| 508 | ENLV | Enlivex Therapeutics Ltd. | 21.99M | -0.99% | 42,608 | - |
| 509 | COEP | Coeptis Therapeutics Holdings, Inc. | 21.63M | -4.62% | 89,163 | - |
| 510 | HOOK | HOOKIPA Pharma Inc. | 21.46M | -1.66% | 38,078 | 50.00M |
| 511 | LSTA | Lisata Therapeutics, Inc. | 21.40M | 1.95% | 4,467 | - |
| 512 | CDIO | Cardio Diagnostics Holdings, Inc. | 20.40M | 7.11% | 2,506,023 | 35.69K |
| 513 | CLDI | Calidi Biotherapeutics, Inc. | 20.28M | -16.67% | 1,289,802 | - |
| 514 | NXTC | NextCure, Inc. | 20.25M | -5.38% | 31,201 | - |
| 515 | RAIN | Rain Enhancement Technologies Holdco, Inc. | 19.88M | -0.75% | 13,736 | - |
| 516 | COCP | Cocrystal Pharma, Inc. | 19.84M | -0.51% | 20,374 | - |
| 517 | INAB | IN8bio, Inc. | 19.68M | -5.07% | 2,130,096 | - |
| 518 | GLYC | GlycoMimetics, Inc. | 19.03M | -2.19% | 1,112,473 | - |
| 519 | CRVO | CervoMed Inc. | 18.82M | -1.94% | 35,328 | 10.07M |
| 520 | CARM | Carisma Therapeutics, Inc. | 18.80M | -2.72% | 174,870 | 20.27M |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 18.68M | -4.29% | 111,709 | 9.78M |
| 522 | LPTX | Leap Therapeutics, Inc. | 18.40M | -0.52% | 301,251 | - |
| 523 | SNTI | Senti Biosciences, Inc. | 18.17M | -1.00% | 8,782 | - |
| 524 | LPCN | Lipocine Inc. | 18.08M | -3.43% | 16,307 | 7.92M |
| 525 | CANF | Can-Fite BioPharma Ltd. | 17.71M | -5.24% | 370,703 | 667.00K |
| 526 | PHGE | BiomX Inc. | 17.43M | 4.94% | 15,318 | - |
| 527 | HCWB | HCW Biologics Inc. | 17.37M | -0.26% | 149,279 | 3.50M |
| 528 | SPRB | Spruce Biosciences, Inc. | 17.35M | -1.20% | 346,445 | 7.10M |
| 529 | MEIP | MEI Pharma, Inc. | 17.32M | -2.62% | 4,700 | - |
| 530 | AFMD | Affimed N.V. | 17.05M | 1.96% | 64,597 | 6.29M |
| 531 | EDSA | Edesa Biotech, Inc. | 16.86M | -2.80% | 113,479 | - |
| 532 | MRKR | Marker Therapeutics, Inc. | 16.81M | -3.68% | 35,997 | 5.40M |
| 533 | SABS | SAB Biotherapeutics, Inc. | 16.80M | -6.67% | 69,690 | 1.51M |
| 534 | ATHA | Athira Pharma, Inc. | 16.79M | -3.21% | 127,370 | - |
| 535 | NRXS | NeurAxis, Inc. | 16.58M | -0.85% | 12,202 | 2.46M |
| 536 | BCTX | BriaCell Therapeutics Corp. | 16.53M | -12.82% | 194,744 | - |
| 537 | TRAW | Traws Pharma, Inc. | 16.36M | -4.48% | 60,380 | 226.00K |
| 538 | KAPA | Kairos Pharma, Ltd. | 16.32M | -4.51% | 121,124 | - |
| 539 | ERNA | Eterna Therapeutics Inc. | 16.18M | -7.08% | 584,673 | 598.00K |
| 540 | SLGL | Sol-Gel Technologies Ltd. | 16.16M | -4.61% | 21,857 | 11.71M |
| 541 | SYBX | Synlogic, Inc. | 15.91M | -4.90% | 4,559 | 2.78M |
| 542 | EVAX | Evaxion Biotech A/S | 15.85M | -4.89% | 179,713 | 3.30M |
| 543 | GOVX | GeoVax Labs, Inc. | 15.76M | 2.45% | 653,486 | 3.09M |
| 544 | CTXR | Citius Pharmaceuticals, Inc. | 15.47M | -2.70% | 130,064 | - |
| 545 | CLRB | Cellectar Biosciences, Inc. | 14.35M | -6.88% | 640,926 | - |
| 546 | APRE | Aprea Therapeutics, Inc. | 14.24M | -7.75% | 20,175 | 1.31M |
| 547 | CING | Cingulate Inc. | 14.10M | 0.95% | 76,683 | - |
| 548 | MTVA | MetaVia Inc. | 13.82M | -2.21% | 19,288 | - |
| 549 | BLRX | BioLineRx Ltd. | 13.78M | -7.47% | 100,531 | 21.99M |
| 550 | LYRA | Lyra Therapeutics, Inc. | 13.46M | 4.10% | 1,098,501 | 1.47M |
| 551 | XTLB | XTL Biopharmaceuticals Ltd. | 13.35M | -6.62% | 10,747 | 46.00K |
| 552 | IMNN | Imunon, Inc. | 13.33M | 5.39% | 82,018 | - |
| 553 | ACXP | Acurx Pharmaceuticals, Inc. | 13.22M | 14.72% | 422,483 | - |
| 554 | IPA | ImmunoPrecise Antibodies Ltd. | 12.95M | -4.22% | 842,285 | 17.27M |
| 555 | NERV | Minerva Neurosciences, Inc. | 12.73M | -2.15% | 27,565 | - |
| 556 | BRTX | BioRestorative Therapies, Inc. | 12.46M | -8.16% | 389,346 | 377.00K |
| 557 | PMCB | PharmaCyte Biotech, Inc. | 12.26M | -2.76% | 60,586 | - |
| 558 | IMRN | Immuron Limited | 11.46M | -5.94% | 2,221 | 3.27M |
| 559 | SNSE | Sensei Biotherapeutics, Inc. | 11.33M | -2.95% | 50,021 | - |
| 560 | INDP | Indaptus Therapeutics, Inc. | 11.30M | 3.71% | 37,384 | - |
| 561 | BCDA | BioCardia, Inc. | 10.59M | -5.71% | 64,104 | 71.00K |
| 562 | CSCI | COSCIENS Biopharma Inc. | 10.55M | -1.45% | 7,740 | 4.83M |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 10.41M | -1.14% | 10,861 | 16.02M |
| 564 | CHRO | Channel Therapeutics Corporation | 10.13M | 3.07% | 42,448 | - |
| 565 | JAGX | Jaguar Health, Inc. | 10.10M | -2.86% | 113,854 | 10.48M |
| 566 | BCLI | Brainstorm Cell Therapeutics Inc. | 9.87M | -3.89% | 12,685 | - |
| 567 | APTO | Aptose Biosciences Inc. | 9.85M | -14.68% | 8,663,993 | - |
| 568 | AEON | AEON Biopharma, Inc. | 9.60M | 11.84% | 18,715,308 | - |
| 569 | CELZ | Creative Medical Technology Holdings, Inc. | 9.44M | -9.85% | 99,855 | 11.00K |
| 570 | EVGN | Evogene Ltd. | 9.28M | 1.21% | 17,657 | 7.48M |
| 571 | TSBX | Turnstone Biologics Corp. | 8.99M | -3.36% | 74,539 | - |
| 572 | AIM | AIM ImmunoTech Inc. | 8.93M | -1.96% | 349,672 | 190.00K |
| 573 | RLMD | Relmada Therapeutics, Inc. | 8.90M | -6.05% | 744,856 | - |
| 574 | OMGA | Omega Therapeutics, Inc. | 8.85M | 3.83% | 21,149,268 | 8.10M |
| 575 | NEUP | Neuphoria Therapeutics Inc. | 8.57M | -3.37% | 29,613 | 662.72K |
| 576 | ABVC | ABVC BioPharma, Inc. | 8.57M | 19.59% | 1,085,073 | 509.79K |
| 577 | PPBT | Purple Biotech Ltd | 8.47M | -3.65% | 6,592 | - |
| 578 | KLTO | Klotho Neurosciences, Inc. | 8.15M | 2.51% | 82,645 | - |
| 579 | VRAX | Virax Biolabs Group Limited | 8.12M | 3.89% | 203,369 | 84.87K |
| 580 | APM | Aptorum Group Limited | 7.82M | -1.34% | 35,120 | - |
| 581 | ICU | SeaStar Medical Holding Corporation | 7.81M | -4.37% | 163,174 | 68.00K |
| 582 | APLM | Apollomics, Inc. | 7.74M | -3.84% | 9,201 | 2.10M |
| 583 | HOTH | Hoth Therapeutics, Inc. | 7.32M | -1.85% | 244,466 | - |
| 584 | DWTX | Dogwood Therapeutics, Inc. | 7.14M | -8.84% | 131,805 | - |
| 585 | CYCN | Cyclerion Therapeutics, Inc. | 7.14M | 4.06% | 152,907 | 194.00K |
| 586 | SLXN | Silexion Therapeutics Corp | 7.11M | -5.07% | 436,937 | - |
| 587 | PSTV | Plus Therapeutics, Inc. | 7.08M | - | 68,918 | 5.73M |
| 588 | ENSC | Ensysce Biosciences, Inc. | 7.05M | -4.26% | 14,930 | 4.42M |
| 589 | BTAI | BioXcel Therapeutics, Inc. | 6.61M | -7.39% | 120,826 | 2.28M |
| 590 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.57M | -4.06% | 573,335 | - |
| 591 | MBIO | Mustang Bio, Inc. | 6.31M | 1.37% | 60,455 | - |
| 592 | XBIO | Xenetic Biosciences, Inc. | 6.21M | 0.46% | 917 | 2.52M |
| 593 | ADXN | Addex Therapeutics Ltd | 6.14M | -0.40% | 7,007 | 701.26K |
| 594 | SNGX | Soligenix, Inc. | 6.10M | - | 14,180 | 364.18K |
| 595 | SILO | Silo Pharma, Inc. | 6.05M | -9.40% | 129,264 | 72.10K |
| 596 | GLTO | Galecto, Inc. | 5.94M | -4.25% | 11,041 | - |
| 597 | AZTR | Azitra, Inc. | 5.82M | -10.02% | 1,237,870 | 97.50K |
| 598 | PBM | Psyence Biomedical Ltd. | 5.76M | -5.11% | 254,546 | - |
| 599 | PHIO | Phio Pharmaceuticals Corp. | 5.69M | -2.91% | 81,615 | - |
| 600 | ONVO | Organovo Holdings, Inc. | 5.67M | -2.61% | 138,139 | 122.00K |
| 601 | RNAZ | TransCode Therapeutics, Inc. | 5.62M | -13.82% | 134,214 | - |
| 602 | CMND | Clearmind Medicine Inc. | 5.50M | 0.78% | 54,944 | - |
| 603 | ALZN | Alzamend Neuro, Inc. | 5.20M | -6.12% | 336,124 | - |
| 604 | PRTG | Portage Biotech Inc. | 5.12M | 1.11% | 6,268 | - |
| 605 | ELAB | PMGC Holdings Inc. | 5.07M | 1.23% | 358,088 | 2.45M |
| 606 | APVO | Aptevo Therapeutics Inc. | 5.06M | 1.76% | 28,948 | - |
| 607 | ADIL | Adial Pharmaceuticals, Inc. | 5.03M | 2.21% | 39,926 | - |
| 608 | KZIA | Kazia Therapeutics Limited | 4.92M | 0.11% | 118,071 | 1.66M |
| 609 | GTBP | GT Biopharma, Inc. | 4.80M | 1.42% | 17,151 | - |
| 610 | SYRS | Syros Pharmaceuticals, Inc. | 4.68M | -0.85% | 569,364 | 386.00K |
| 611 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.41M | 0.70% | 67,880 | 1.00M |
| 612 | OCEA | Ocean Biomedical, Inc. | 4.41M | -9.12% | 18,710,058 | - |
| 613 | PLRZ | Polyrizon Ltd. | 4.36M | -3.70% | 22,435 | - |
| 614 | TOVX | Theriva Biologics, Inc. | 4.31M | -3.73% | 23,915 | - |
| 615 | NCNA | NuCana plc | 4.28M | 2.83% | 84,012 | - |
| 616 | ALLR | Allarity Therapeutics, Inc. | 4.23M | 1.44% | 512,752 | - |
| 617 | GLMD | Galmed Pharmaceuticals Ltd. | 4.07M | 6.00% | 28,459 | - |
| 618 | OGEN | Oragenics, Inc. | 3.98M | 2.55% | 450,439 | - |
| 619 | ATNF | 180 Life Sciences Corp. | 3.97M | -2.34% | 25,354 | - |
| 620 | SNPX | Synaptogenix, Inc. | 3.89M | 1.06% | 5,798 | - |
| 621 | MBRX | Moleculin Biotech, Inc. | 3.84M | -8.57% | 1,625,735 | - |
| 622 | LIPO | Lipella Pharmaceuticals Inc. | 3.80M | -8.19% | 234,487 | 483.53K |
| 623 | ARTL | Artelo Biosciences, Inc. | 3.74M | -3.33% | 18,066 | - |
| 624 | CNSP | CNS Pharmaceuticals, Inc. | 3.71M | -13.87% | 664,647 | - |
| 625 | GRI | GRI Bio, Inc. | 3.71M | -4.64% | 326,005 | - |
| 626 | THAR | Tharimmune, Inc. | 3.67M | 1.06% | 10,926 | - |
| 627 | EYEN | Eyenovia, Inc. | 3.52M | -2.89% | 88,386 | 31.83K |
| 628 | CERO | CERo Therapeutics Holdings, Inc. | 3.43M | -12.68% | 461,987 | - |
| 629 | TTNP | Titan Pharmaceuticals, Inc. | 3.36M | -3.67% | 11,243 | - |
| 630 | GNPX | Genprex, Inc. | 3.34M | -0.61% | 1,255,649 | - |
| 631 | ONCO | Onconetix, Inc. | 3.33M | -4.50% | 452,261 | 1.87M |
| 632 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.31M | -4.88% | 773,229 | 462.61K |
| 633 | MTNB | Matinas BioPharma Holdings, Inc. | 3.26M | 9.97% | 701,978 | - |
| 634 | NLSP | NLS Pharmaceutics AG | 3.16M | -4.88% | 90,134 | - |
| 635 | NBY | NovaBay Pharmaceuticals, Inc. | 3.08M | -2.10% | 80,338 | 13.84M |
| 636 | SCNI | Scinai Immunotherapeutics Ltd. | 3.00M | 4.76% | 5,770 | 452.00K |
| 637 | XRTX | XORTX Therapeutics Inc. | 2.94M | -13.23% | 139,060 | - |
| 638 | ZVSA | ZyVersa Therapeutics, Inc. | 2.86M | - | 71,080 | - |
| 639 | LIXT | Lixte Biotechnology Holdings, Inc. | 2.86M | -6.61% | 45,933 | - |
| 640 | VINC | Vincerx Pharma, Inc. | 2.78M | -0.80% | 60,596 | - |
| 641 | TCRT | Alaunos Therapeutics, Inc. | 2.69M | 3.70% | 11,132 | 7.00K |
| 642 | QLGN | Qualigen Therapeutics, Inc. | 2.61M | -2.26% | 11,051 | - |
| 643 | PALI | Palisade Bio, Inc. | 2.61M | -3.76% | 86,028 | - |
| 644 | ATXI | Avenue Therapeutics, Inc. | 2.60M | -2.86% | 41,132 | - |
| 645 | ENVB | Enveric Biosciences, Inc. | 2.59M | -0.73% | 203,337 | - |
| 646 | DRMA | Dermata Therapeutics, Inc. | 2.55M | 3.31% | 161,229 | - |
| 647 | PCSA | Processa Pharmaceuticals, Inc. | 2.51M | -4.07% | 112,435 | - |
| 648 | ENTO | Entero Therapeutics, Inc. | 2.35M | -6.04% | 50,769 | - |
| 649 | BDRX | Biodexa Pharmaceuticals Plc | 2.15M | -2.37% | 36,614 | 104.90K |
| 650 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.14M | -1.73% | 75,168 | 74.00K |
| 651 | SLRX | Salarius Pharmaceuticals, Inc. | 1.93M | -0.74% | 46,951 | - |
| 652 | HEPA | Hepion Pharmaceuticals, Inc. | 1.81M | -9.20% | 4,903,026 | - |
| 653 | PTIX | Protagenic Therapeutics, Inc. | 1.80M | 2.12% | 62,033 | - |
| 654 | REVB | Revelation Biosciences, Inc. | 1.74M | -2.05% | 22,418 | - |
| 655 | KTTA | Pasithea Therapeutics Corp. | 1.65M | -3.70% | 46,375 | - |
| 656 | SPRC | SciSparc Ltd. | 1.60M | -4.37% | 130,306 | 1.75M |
| 657 | CDT | Conduit Pharmaceuticals Inc. | 1.38M | -3.36% | 583,509 | - |
| 658 | TNFA | TNF Pharmaceuticals, Inc. | 1.32M | -2.62% | 318,931 | - |
| 659 | ADTX | Aditxt, Inc. | 1.30M | -22.98% | 271,150,045 | 212.11K |
| 660 | VRPX | Virpax Pharmaceuticals, Inc. | 1.28M | -8.69% | 1,767,351 | - |
| 661 | SCPX | Scorpius Holdings, Inc. | 1.07M | 8.37% | 2,150,207 | 10.04M |
| 662 | TCBP | TC Biopharm (Holdings) Plc | 1.03M | -4.58% | 164,134 | - |
| 663 | WINT | Windtree Therapeutics, Inc. | 782.11K | -9.38% | 295,153 | - |